Use of Care Services by Patients With Borderline Personality Disorder (EpiB)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02829658|
Recruitment Status : Completed
First Posted : July 12, 2016
Last Update Posted : May 12, 2017
Borderline personality disorder (BPD) is characterized by a pervasive pattern of instability and impulsivity. Several North American prospective studies support the high level of mental health care utilization in this population. There is little data in other systems of health organization, such as France. Furthermore, little is known on the variables associated with the mental health service utilization among BPD patients.
The main objective was to compare the utilization of mental health care among BPD patients, to the general population and patients with another personality disorder (PD) and to describe the demographic and clinical factors associated with the group of patients who use the most health care.
|Condition or disease||Intervention/treatment|
|Borderline Personality Disorder||Behavioral: Psychologic test Other: No intervention|
|Study Type :||Observational|
|Actual Enrollment :||98 participants|
|Official Title:||Use of Care Services by Patients With Borderline Personality Disorder|
|Study Start Date :||February 2009|
|Actual Primary Completion Date :||June 2010|
|Actual Study Completion Date :||June 2010|
Psychiatric patients group
Patient groups were composed with: BPD, other PD and assessed Psychologic test
Behavioral: Psychologic test
Assessment by a psychologist including the Structured Interview for Diagnostic and Statistical Manual (DSM)-IV Personality Disorders (SIDP-IV) was given straight to those who had a score above 28. This questionnaire allowed us to distinguish one group of subjects with BPD and a group with other PD (without BPD). Clinical evaluation included Axis I (MINI), Axis II (SIDP-IV), psychopathological features (YSQ-I, Defense Style Questionnaire (DSQ-40), demographic variables and therapeutic alliance (Haq-II).
Matched controls (age, sex) composed the 3rd and 4th group (BPD control and other PD control). They were randomly chosen in the health database insurance previously used. They had no intervention.
Other: No intervention
- Compare data among BPD Patients and general population [ Time Frame: during five years previously to the inclusion ]Utilization of mental health care
- Hospitalizations [ Time Frame: During five years previously to the inclusion ]Compare hospitalizations between BPD patients and general population
- Demographics data [ Time Frame: Inclusion ]Compare demographic data between BPD patient and general population
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02829658
|University Hospital of Toulouse|
|Toulouse, France, 31000|
|Principal Investigator:||CAILHOL Lionel, MD||University Hospital, Toulouse|